Literature DB >> 30182751

Resting EEG Measures of Brain Arousal in a Multisite Study of Major Depression.

Christine Ulke1,2, Craig E Tenke3,4, Jürgen Kayser3,4, Christian Sander1,2, Daniel Böttger1,2, Lidia Y X Wong4, Jorge E Alvarenga4, Maurizio Fava5, Patrick J McGrath3,4, Patricia J Deldin6, Melvin G Mcinnis7, Madhukar H Trivedi8, Myrna M Weissman3,4, Diego A Pizzagalli9, Ulrich Hegerl1,2, Gerard E Bruder3,4.   

Abstract

Several studies have found upregulated brain arousal during 15-minute EEG recordings at rest in depressed patients. However, studies based on shorter EEG recording intervals are lacking. Here we aimed to compare measures of brain arousal obtained from 2-minute EEGs at rest under eyes-closed condition in depressed patients and healthy controls in a multisite project-Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC). We expected that depressed patients would show stable and elevated brain arousal relative to controls. Eighty-seven depressed patients and 36 healthy controls from four research sites in the United States were included in the analyses. The Vigilance Algorithm Leipzig (VIGALL) was used for the fully automatic classification of EEG-vigilance stages (indicating arousal states) of 1-second EEG segments; VIGALL-derived measures of brain arousal were calculated. We found that depressed patients scored higher on arousal stability ( Z = -2.163, P = .015) and A stages (dominant alpha activity; P = .027) but lower on B1 stages (low-voltage non-alpha activity, P = .008) compared with healthy controls. No significant group differences were observed in Stage B2/3. In summary, we were able to demonstrate stable and elevated brain arousal during brief 2-minute recordings at rest in depressed patients. Results set the stage for examining the value of these measures for predicting clinical response to antidepressants in the entire EMBARC sample and evaluating whether an upregulated brain arousal is particularly characteristic for responders to antidepressants.

Entities:  

Keywords:  EEG-vigilance; EMBARC; VIGALL 2.1; brain arousal regulation; electroencephalogram; major depressive disorder

Mesh:

Year:  2018        PMID: 30182751      PMCID: PMC6384132          DOI: 10.1177/1550059418795578

Source DB:  PubMed          Journal:  Clin EEG Neurosci        ISSN: 1550-0594            Impact factor:   1.843


  9 in total

1.  Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial.

Authors:  Ian A Cook; Aimee M Hunter; Marissa M Caudill; Michelle J Abrams; Andrew F Leuchter
Journal:  J Psychiatr Res       Date:  2020-02-26       Impact factor: 4.791

2.  Increased behavioral inhibition trait and negative stress coping in non-rapid eye movement parasomnias.

Authors:  Markus Ramm; Alexandra Urbanek; Annette Failing; Peter Young; Christoph Scherfler; Birgit Högl; Anna Heidbreder
Journal:  J Clin Sleep Med       Date:  2020-10-15       Impact factor: 4.062

3.  Frontal theta and posterior alpha in resting EEG: A critical examination of convergent and discriminant validity.

Authors:  Ezra E Smith; Craig E Tenke; Patricia J Deldin; Madhukar H Trivedi; Myrna M Weissman; Randy P Auerbach; Gerard E Bruder; Diego A Pizzagalli; Jürgen Kayser
Journal:  Psychophysiology       Date:  2019-10-02       Impact factor: 4.016

Review 4.  EEG Neurofeedback for Anxiety Disorders and Post-Traumatic Stress Disorders: A Blueprint for a Promising Brain-Based Therapy.

Authors:  J A Micoulaud-Franchi; C Jeunet; A Pelissolo; T Ros
Journal:  Curr Psychiatry Rep       Date:  2021-10-29       Impact factor: 5.285

5.  Possible Effects of Bright Light Therapy on Electroencephalogram-Vigilance in the Treatment of Depression in Adolescents: A Pilot Study.

Authors:  Christoph Berger; Alexander Dück; Stephanie Gest; Lena Jonas; Michael Kölch; Franziska Martin; Olaf Reis; Jennifer Schroth; Tanja Legenbauer; Martin Holtmann
Journal:  Front Psychiatry       Date:  2022-05-12       Impact factor: 5.435

6.  Structural brain measures linked to clinical phenotypes in major depression replicate across clinical centres.

Authors:  Meichen Yu; Nicholas Cullen; Kristin A Linn; Desmond J Oathes; Darsol Seok; Philip A Cook; Romain Duprat; Irem Aselcioglu; Tyler M Moore; Christos Davatzikos; Maria A Oquendo; Myrna M Weissman; Russell T Shinohara; Yvette I Sheline
Journal:  Mol Psychiatry       Date:  2021-02-15       Impact factor: 13.437

7.  Brain arousal regulation and depressive symptomatology in adults with attention-deficit/hyperactivity disorder (ADHD).

Authors:  Jue Huang; Christine Ulke; Maria Strauss
Journal:  BMC Neurosci       Date:  2019-08-20       Impact factor: 3.288

8.  Fatigue and brain arousal in patients with major depressive disorder.

Authors:  Galina Surova; Christine Ulke; Frank Martin Schmidt; Tilman Hensch; Christian Sander; Ulrich Hegerl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-12-04       Impact factor: 5.270

9.  The biological dimensions of transcendent states: A randomized controlled trial.

Authors:  Dawson Church; Amy Yang; Jeffrey Fannin; Katharina Blickheuser
Journal:  Front Psychol       Date:  2022-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.